5. Actos - Top 10 Warnings and Recalls
Drug: Actos
2006 sales: $3.05 billion
Manufacturer: Takeda
Safety concern: “black box;” heart failure
Related Articles:
> Takeda touts Actos as heart attack-free. Report
> Actos on a good-news roll. Report
> Actos study points to reduction in heart attacks, strokes. Report
> Diabetes drug helps reduce rate of strokes. Report
> Avandia, Actos don't boost death risk. Report
Be the first to comment
More stories about Actos
Comments
Post new comment
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
